Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, said: “We would like to thank the dedicated physicians and pyoderma gangrenosum patients for their participation in this ...

Although a number of diseases are included in this setting, the two prototypic forms are pyoderma gangrenosum (PG) and Sweet's syndrome (SS ... was reported in an adolescent with severe cutaneous ...

Riedemann, Chief Executive Officer and Founder of InflaRx, said: “We would like to thank the dedicated physicians and pyoderma gangrenosum patients for their participation in ... Hypersensitivity ...

Tattoo popularity is rising, but research shows that tattoo health risks including toxins, infections, immune issues, and ...

Late Tuesday and early Wednesday, there will be a chance of showers and thunderstorms before 2 a.m., then showers likely and possibly a thunderstorm between 2 a.m. and 4 a.m., then a chance of ...

This medication is approved to treat moderate to severe UC in people who haven’t responded well to other treatments. It blocks the activity of TNF. Infliximab is given as an IV infusion.

Backers of Jena, Germany-based Inflarx NV have turned their attention to the rest of the pipeline after the stock-jolting news from an independent data monitoring committee (DMC) responsible for the ...

It is with deep sadness and heavy hearts that we announce the passing of Kylie, who departed this world on December 29, 2023.

The western part of the state will be under a marginal risk for possible strong/severe storms overnight. Storms will be around on Tuesday morning, but the main severe threat will be in the ...